WILENTIN caps 300 mg bte 100 pce

7680679000025 CH-67900 A16AX12 07.99.0.

Active substances:

WILENTIN caps 300 mg bte 100 pce
WILENTIN caps 300 mg bte 100 pce
WILENTIN caps 300 mg bte 100 pce
1 / 3
google

Details

Product number
6790003
CPT
-
Packaging group
100
Unit
Kapsel(n)
Composition
trientini dihydrochloridum 300 mg, acidum stearicum, Kapselhülle: gelatina, E 171, aqua, Drucktinte: lacca, E 172 (nigrum), kalii hydroxidum, pro capsula.

Articles (1)

Wilentin 300 mg, Hartkapseln
Kapseln
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/09/2026
Patient information leaflet
Français
26/09/2026
Patient information leaflet
Italien
26/09/2026
Professional SmPC
Allemand
26/09/2026
Professional SmPC
Français
26/09/2026
Professional SmPC
Italien
26/09/2026

Detailed composition

Substance Quantity Type Category
trientini dihydrochloridum
300.0 MG Substance Wirkstoff (Principe actif)
acidum stearicum
- Substance HNIDK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
aqua
- Substance HNIDK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
kalii hydroxidum
- Substance HNIDK

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
67900
Drug name
Wilentin, Hartkapseln
Galenic form
KAHA
ATC Code
A16AX12
Authorization status
Z
Dispensation category
B
First authorization
08/12/2021
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen

Packaging details

Description (FR)
WILENTIN caps 300 mg bte 100 pce
Description (DE)
WILENTIN Kaps 300 mg Ds 100 Stk
Market launch
08/12/2021
Narcotic (BTM)
No

Other packaging sizes

WILENTIN caps 250 mg bte 100 pce
100 KAP
View
Buy us a coffee Explore the data